Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH)

CONCLUSIONS: If compared to placebo, the PCSK9 inhibitor evolocumab combined with statins resulted in a greater decrease in LDL-C and plaque neovascularization in Chinese patients with PCAD.PMID:38493669 | DOI:10.1016/j.atherosclerosis.2024.117471

Source: Atherosclerosis - March 17, 2024 Category: Cardiology Authors: Yanyan Han Ling Ren Xiang Fei Jingjing Wang Tao Chen Jun Guo Qi Wang Source Type: research